Table 1.
Baseline Demographics for the full cohort (n=50) and for patients with recurrent stroke (n=16) versus without recurrent stroke (n=34) with p value for difference.
| Full cohort (n=50) | Recurrent stroke (n=15) | No recurrent stroke (n=35) | p value | |
|---|---|---|---|---|
| Age | 68.1±14.6 | 71.3±14.1 | 66.8±14.1 | 0.316 |
| Male sex | 25, 50% | 7, 46.7% | 18, 51.4% | 0.758 |
| Prior stroke | 13, 26% | 4, 26.7% | 9, 25.7% | 0.994 |
| Hypertension | 40, 80% | 13, 86.7% | 27, 77.1% | 0.440 |
| Hyperlipidemia | 28, 56% | 9, 60% | 19, 54.3% | 0.709 |
| Diabetes Mellitus | 19, 38% | 7, 46.7% | 12, 34.3% | 0.409 |
| Atrial Fibrillation | 8, 16% | 4, 26.7% | 4, 11.4% | 0.178 |
| Current smoking | 10, 20% | 3, 20% | 7, 20.6% | 1.000 |
| Stenosis 70–99% | 30, 60% | 12, 80% | 18, 51.4% | 0.059 |
| Dual antiplatelet therapy | 26, 52% | 10, 66.7% | 16, 45.7% | 0.174 |
| Mono antiplatelet therapy | 16, 32% | 4, 26.7% | 12, 34.3% | 0.597 |
| Anticoagulation | 8, 16% | 2, 13.3% | 6, 17.1% | 0.736 |
| Statin therapy | 45, 90% | 13, 86.7% | 32, 91.4% | 0.607 |
| Index stroke core volume (mL) | 4.4±11.8 | 8.8±20.2 | 2.5±4.5 | 0.085 |
| Baseline Tmax6 hypoperfusion volume (mL) | 30.5±51.5 | 67.5±69.1 | 14.6±31.5 | <0.001 |
| Absolute mismatch volume (mL) | 26.1±48.0 | 58.7±65.4 | 12.1±29.7 | 0.001 |
Continuous variables presented as mean±SD, binary variables as n,%. Intergroup differences tested with Student’s t-test for continuous variables and the chi-squared for binary variables.